Titre :
  • Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study.
Auteur : Raoul, Jean-Luc ; Van Laethem, Jean-Luc ; Peeters, Marc ; Brezault, Catherine ; Husseini, Fares ; Cals, Laurent ; Nippgen, Johannes ; Loos, Anja-Helena ; Rougier, Philippe
Informations sur la publication : BMC cancer, 9, (page 112)
Statut de publication : Publié, 2009
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antibodies, Monoclonal -- administration & dosage -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Camptothecin -- administration & dosage -- adverse effects -- analogs & derivatives
Colorectal Neoplasms -- drug therapy -- pathology
Diarrhea -- chemically induced
Disease Progression
Dose-Response Relationship, Drug
Drug Administration Schedule
Exanthema -- chemically induced
Female
Fluorouracil -- administration & dosage -- adverse effects
Follow-Up Studies
Humans
Infusions, Intravenous
Leucovorin -- administration & dosage -- adverse effects
Leukopenia -- chemically induced
Male
Middle Aged
Neoplasm Metastasis
Survival Analysis
Treatment Outcome
Vomiting -- chemically induced
Note : Clinical Trial, Phase I
Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:1471-2407 
info:doi/10.1186/1471-2407-9-112
info:pii/1471-2407-9-112
info:pmid/19366444
info:pmcid/PMC2678147